Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
Public ClinicalTrials.gov record NCT01641081. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Randomized, Placebo-controlled, Double-blind, Double-dummy, 5-period Complete Crossover Study of the Bronchodilator Effects of Formoterol Fumarate Inhalation Powder in Patients With Mild to Moderate Asthma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Phase II study is to evaluate efficacy and safety of inhaled formoterol fumarate in the Pressair DPI compared to the Foradil Aerolizer in patients with mild to moderate asthma. This study will include a screening visit followed by a 4 month treatment period.
Study identification
- NCT ID
- NCT01641081
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 174 participants
Conditions and interventions
Conditions
Interventions
- Formoterol Fumarate in the Pressair DPI, Low Dose Drug
- Formoterol Fumarate in the Pressair DPI, High Dose Drug
- Foradil Aerolizer, Low Dose Drug
- Foradil Aerolizer, High Dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2012 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- Feb 2013 (Actual)
- Last update posted
- Feb 28, 2017
2012 – 2013
United States locations
- U.S. sites
- 29
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 909 | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site 2066 | Encinitas | California | 92024 | — |
| Forest Investigative Site 1624 | Los Angeles | California | 90025 | — |
| Forest Investigative Site 1995 | Mission Viejo | California | 92691 | — |
| Forest Investigative Site 1347 | San Jose | California | 95117 | — |
| Forest Investigative Site 1996 | Centennial | Colorado | 80112 | — |
| Forest Investigative Site 1137 | Colorado Springs | Colorado | 80907 | — |
| Forest Investigative Site 1998 | Denver | Colorado | 80230 | — |
| Forest Investigative Site 2047 | Tampa | Florida | 33613 | — |
| Forest Investigative Site 1536 | Louisville | Kentucky | 40215 | — |
| Forest Investigative Site 1333 | Baltimore | Maryland | 21236 | — |
| Forest Investigative Site 1431 | North Dartmouth | Massachusetts | 02747 | — |
| Forest Investigative Site 2041 | Minneapolis | Minnesota | 55402 | — |
| Forest Investigative Site 1599 | St Louis | Missouri | 63141 | — |
| Forest Investigative Site 1609 | Bellevue | Nebraska | 68123 | — |
| Forest Investigative Site 1999 | Skillman | New Jersey | 08558 | — |
| Forest Investigative Site 1153 | Raleigh | North Carolina | 27607 | — |
| Forest Investigative Site 1134 | Canton | Ohio | 44718 | — |
| Forest Investigative Site 1806 | Cincinnati | Ohio | 45231 | — |
| Forest Investigative Site 1176 | Oklahoma City | Oklahoma | 73120 | — |
| Forest Investigative Site 2043 | Medford | Oregon | 97504 | — |
| Forest Investigative Site 1580 | Portland | Oregon | 97202 | — |
| Forest Investigative Site 2025 | Charleston | South Carolina | 29407 | — |
| Forest Investigative Site 1155 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 1332 | El Paso | Texas | 79903 | — |
| Forest Investigative Site 1370 | New Braunfels | Texas | 78130 | — |
| Forest Investigative Site 1699 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 2011 | Seattle | Washington | 98115 | — |
| Forest Investigative Site 1997 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01641081, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01641081 live on ClinicalTrials.gov.